TrialInvestigational new drugs2024

Phase I/II trial of BMS-986,205 and nivolumab as first line therapy in hepatocellular carcinoma.

Jasmine C Huynh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.